Pinnacle Medicines | $89,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
Mirage | $75,000,000 | (Mar 27, 2026)
Erbi Biosystems, Inc.
United States
- Stoneham, Massachusetts
- 04/01/2022
- Unknown
- $4,000,000
Erbi Biosystems is revolutionizing cell therapy and bioprocessing process development with the Breez, a fully automated 2 mL TruePerfusion™ bioreactor. Scarce and expensive raw materials no longer restrict generation of process development data enabling improved CMC. A single 2mL volume cassette can deliver up to 400M (CHO and T-cells), sufficient for most development needs and a number of CAR-T clinical dose regimes.
The platform offers a 90% footprint reduction using disposable, functionally closed single-use cassettes with proprietary microfluidic technology processes capable of performing activation, transduction, intensified growth, and diafiltration steps. It offers closed-loop control of pH, total cell density (OD), dissolved oxygen, and CO2 measurements. The integrated online sensors and intuitive software deliver sophisticated feeding strategies, increased cell concentration, low shear, bubble-free mixing with high kLa resulting in performance far exceeding the static and benchtop reactors typically used today.
#CellTherapy4All #CellTherapyforAll
- Industry Biotechnology Research
- Website https://erbi-bio.com/
- LinkedIn https://www.linkedin.com/company/erbi-biosystems/about/
Related People
Michael ChiuFounder
United States -
Somerville, Massachusetts
Entrepreneurial general manager focused on developing and commercializing early-stage technologies. Broad range of experience from startups to S&P500 companies.
Founder, CEO of VC-backed startup with successful exit.
GM of a global technology business unit with >$60M in revenues.
Led development of multiple new products from concept to successful market introduction. Responsible for marketing, engineering, supply-chain, applications and support.
Experience with corporate operations, finance, governance and M&A.
Specialties: Leading entrepreneurial teams
New product development and marketing
Strategy and systems architecture of complex technologies and businesses
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)
Payy | $6,000,000 | (Mar 27, 2026)
Conntour | $7,000,000 | (Mar 27, 2026)
KilgourMD | Undisclosed Amount | (Mar 27, 2026)
Terrestrial | $50,000,000 | (Mar 27, 2026)
Krane | $9,000,000 | (Mar 26, 2026)
Zalos (YC F25) | $3,600,000 | (Mar 26, 2026)